Fatemeh Seyednasrollah1, Johanna Mäkelä2, Niina Pitkänen1, Markus Juonala1, Nina Hutri-Kähönen1, Terho Lehtimäki1, Jorma Viikari1, Tanika Kelly1, Changwei Li1, Lydia Bazzano1, Laura L Elo1, Olli T Raitakari1. 1. From the Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Finland (F.S., J.M., L.L.E.); Department of Mathematics and Statistics (F.S.), Research Centre of Applied and Preventive Cardiovascular Medicine (N.P., O.T.R.), and Department of Medicine (M.J., J.V.), University of Turku, Finland; Division of Medicine (M.J., J.V.) and Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital, Finland; Department of Pediatrics (N.H.-K.) and School of Medicine (T.L.), University of Tampere, Finland; Tampere University Hospital, Finland (N.H.-K.); Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland (T.L.); Tulane University Health Sciences Center, New Orleans, LA (T.K., L.B.); and Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens (C.L.). 2. From the Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Finland (F.S., J.M., L.L.E.); Department of Mathematics and Statistics (F.S.), Research Centre of Applied and Preventive Cardiovascular Medicine (N.P., O.T.R.), and Department of Medicine (M.J., J.V.), University of Turku, Finland; Division of Medicine (M.J., J.V.) and Clinical Physiology and Nuclear Medicine (O.T.R.), Turku University Hospital, Finland; Department of Pediatrics (N.H.-K.) and School of Medicine (T.L.), University of Tampere, Finland; Tampere University Hospital, Finland (N.H.-K.); Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland (T.L.); Tulane University Health Sciences Center, New Orleans, LA (T.K., L.B.); and Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens (C.L.). jolepp@utu.fi.
Abstract
BACKGROUND: Obesity is a known risk factor for cardiovascular disease. Early prediction of obesity is essential for prevention. The aim of this study is to assess the use of childhood clinical factors and the genetic risk factors in predicting adulthood obesity using machine learning methods. METHODS AND RESULTS: A total of 2262 participants from the Cardiovascular Risk in YFS (Young Finns Study) were followed up from childhood (age 3-18 years) to adulthood for 31 years. The data were divided into training (n=1625) and validation (n=637) set. The effect of known genetic risk factors (97 single-nucleotide polymorphisms) was investigated as a weighted genetic risk score of all 97 single-nucleotide polymorphisms (WGRS97) or a subset of 19 most significant single-nucleotide polymorphisms (WGRS19) using boosting machine learning technique. WGRS97 and WGRS19 were validated using external data (n=369) from BHS (Bogalusa Heart Study). WGRS19 improved the accuracy of predicting adulthood obesity in training (area under the curve [AUC=0.787 versus AUC=0.744, P<0.0001) and validation data (AUC=0.769 versus AUC=0.747, P=0.026). WGRS97 improved the accuracy in training (AUC=0.782 versus AUC=0.744, P<0.0001) but not in validation data (AUC=0.749 versus AUC=0.747, P=0.785). Higher WGRS19 associated with higher body mass index at 9 years and WGRS97 at 6 years. Replication in BHS confirmed our findings that WGRS19 and WGRS97 are associated with body mass index. CONCLUSIONS: WGRS19 improves prediction of adulthood obesity. Predictive accuracy is highest among young children (3-6 years), whereas among older children (9-18 years) the risk can be identified using childhood clinical factors. The model is helpful in screening children with high risk of developing obesity.
BACKGROUND:Obesity is a known risk factor for cardiovascular disease. Early prediction of obesity is essential for prevention. The aim of this study is to assess the use of childhood clinical factors and the genetic risk factors in predicting adulthood obesity using machine learning methods. METHODS AND RESULTS: A total of 2262 participants from the Cardiovascular Risk in YFS (Young Finns Study) were followed up from childhood (age 3-18 years) to adulthood for 31 years. The data were divided into training (n=1625) and validation (n=637) set. The effect of known genetic risk factors (97 single-nucleotide polymorphisms) was investigated as a weighted genetic risk score of all 97 single-nucleotide polymorphisms (WGRS97) or a subset of 19 most significant single-nucleotide polymorphisms (WGRS19) using boosting machine learning technique. WGRS97 and WGRS19 were validated using external data (n=369) from BHS (Bogalusa Heart Study). WGRS19 improved the accuracy of predicting adulthood obesity in training (area under the curve [AUC=0.787 versus AUC=0.744, P<0.0001) and validation data (AUC=0.769 versus AUC=0.747, P=0.026). WGRS97 improved the accuracy in training (AUC=0.782 versus AUC=0.744, P<0.0001) but not in validation data (AUC=0.749 versus AUC=0.747, P=0.785). Higher WGRS19 associated with higher body mass index at 9 years and WGRS97 at 6 years. Replication in BHS confirmed our findings that WGRS19 and WGRS97 are associated with body mass index. CONCLUSIONS: WGRS19 improves prediction of adulthood obesity. Predictive accuracy is highest among young children (3-6 years), whereas among older children (9-18 years) the risk can be identified using childhood clinical factors. The model is helpful in screening children with high risk of developing obesity.
Authors: Elsie M Taveras; Matthew W Gillman; Michelle-Marie Peña; Susan Redline; Sheryl L Rifas-Shiman Journal: Pediatrics Date: 2014-06 Impact factor: 7.124
Authors: J R González; M N Estévez; P S Giralt; A Cáceres; L M L Pérez; M González-Carpio; F Ballester; J Sunyer; R Rodríguez-López Journal: Pediatr Obes Date: 2013-04-29 Impact factor: 4.000
Authors: Mervi Oikonen; Emmi Tikkanen; Jonna Juhola; Tarja Tuovinen; Ilkka Seppälä; Markus Juonala; Leena Taittonen; Vera Mikkilä; Mika Kähönen; Samuli Ripatti; Jorma Viikari; Terho Lehtimäki; Aki S Havulinna; Frank Kee; Christopher Newton-Cheh; Leena Peltonen; Nicholas J Schork; Sarah S Murray; Gerald S Berenson; Wei Chen; Sathanur R Srinivasan; Veikko Salomaa; Olli T Raitakari Journal: Hypertension Date: 2011-10-24 Impact factor: 10.190
Authors: Christina Kleiser; Angelika Schaffrath Rosario; Gert B M Mensink; Reinhild Prinz-Langenohl; Bärbel-Maria Kurth Journal: BMC Public Health Date: 2009-02-02 Impact factor: 3.295
Authors: Miguel Seral-Cortes; Sergio Sabroso-Lasa; Pilar De Miguel-Etayo; Marcela Gonzalez-Gross; Eva Gesteiro; Cristina Molina-Hidalgo; Stefaan De Henauw; Frederic Gottrand; Christina Mavrogianni; Yannis Manios; Maria Plada; Kurt Widhalm; Anthony Kafatos; Éva Erhardt; Aline Meirhaeghe; Diego Salazar-Tortosa; Jonatan Ruiz; Luis A Moreno; Luis Mariano Esteban; Idoia Labayen Journal: Sci Rep Date: 2021-02-04 Impact factor: 4.379
Authors: Miguel Seral-Cortes; Sergio Sabroso-Lasa; Pilar De Miguel-Etayo; Marcela Gonzalez-Gross; Eva Gesteiro; Cristina Molina-Hidalgo; Stefaan De Henauw; Éva Erhardt; Laura Censi; Yannis Manios; Eva Karaglani; Kurt Widhalm; Anthony Kafatos; Laurent Beghin; Aline Meirhaeghe; Diego Salazar-Tortosa; Jonatan R Ruiz; Luis A Moreno; Luis Mariano Esteban; Idoia Labayen Journal: Nutrients Date: 2020-12-16 Impact factor: 5.717